http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060056417-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42b66fd6ac8d432f925152eef843ebe7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 1999-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28124eb58a0d1c4c1adfd7640ca33c1
publicationDate 2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060056417-A
titleOfInvention New Uses of Pramipexole
abstract The present invention discloses novel uses and treatments including carvegoline, pramipexole, and novel combination formulations of carvegoline and pramipexole for use in the treatment of patients. Herein we disclose the use of carvegoline or pramipexole for treating PSP and MSA. Also disclosed is a combination therapy of cabergoline and pramipexole, which is simultaneously provided to patients in need of treatment of various central nervous system diseases, particularly Parkinson's disease (PD), and also PSP and MSA.
priorityDate 1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140449443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425129886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452107106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450306487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34359

Total number of triples: 54.